Xencor, Inc.
US ˙ NasdaqGM ˙ US98401F1057

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Kevin Charles Gorman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Kevin Charles Gorman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:NBIX / Neurocrine Biosciences, Inc. Director 514.596
US:XNCR / Xencor, Inc. Director 18.905
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Kevin Charles Gorman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb XNCR / Xencor, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i XNCR / Xencor, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-02-13 XNCR GORMAN KEVIN CHARLES 53 19,1200 53 19,1200 1.013 293 26.8400 410 40,43

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XNCR / Xencor, Inc. Insider Trades
Insidersalg XNCR / Xencor, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i XNCR / Xencor, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XNCR / Xencor, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Kevin Charles Gorman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-11 2025-08-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -106.322 514.596 -17,12 126,41 -13.440.281 65.050.646
2025-08-11 2025-08-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 106.322 620.918 20,66 35,99 3.826.529 22.346.839
2025-06-16 2025-06-16 4 XNCR Xencor Inc
Common Stock
S - Sale X -3.173 18.905 -14,37 9,22 -29.255 174.304
2025-06-16 2025-06-12 4 XNCR Xencor Inc
Common Stock
A - Award 13.686 22.078 163,08
2025-05-29 2025-05-27 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -9.613 514.596 -1,83 120,38 -1.157.211 61.946.964
2025-02-14 2025-02-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.012 524.209 -0,57 116,68 -351.450 61.166.384
2025-02-14 2025-02-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 5.603 527.221 1,07
2025-02-14 2025-02-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.832 521.618 -0,54 116,69 -330.465 60.867.344
2025-02-14 2025-02-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 5.376 524.450 1,04
2025-02-12 2025-02-10 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.274 519.074 -0,44 118,37 -269.167 61.441.388
2025-02-12 2025-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 4.318 521.348 0,84
2025-02-04 2025-01-31 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.707 517.030 -0,52 152,92 -413.967 79.066.606
2025-02-04 2025-01-31 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 5.141 519.737 1,00
2025-01-29 2025-01-27 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -146.105 514.596 -22,11 149,46 -21.836.503 76.910.283
2025-01-29 2025-01-27 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 146.105 660.701 28,39 32,99 4.820.004 21.796.526
2024-10-01 2024-09-27 4 XNCR Xencor Inc
Common Stock
S - Sale X -2.654 8.392 -24,03 20,68 -54.885 173.547
2024-06-17 2024-06-13 4 XNCR Xencor Inc
Common Stock
A - Award 5.986 11.046 118,30
2024-02-15 2024-02-13 4 XNCR Xencor Inc
Common Stock
P - Purchase 53 5.060 1,06 19,12 1.013 96.747
2024-02-15 2024-02-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.832 514.596 -0,55 133,02 -376.700 68.449.347
2024-02-14 2024-02-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 2.312 512.052 0,45 43,24 99.971 22.141.128
2024-02-14 2024-02-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 2.778 509.740 0,55 35,99 99.980 18.345.543
2024-02-08 2024-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.274 506.962 -0,45 134,15 -305.052 68.007.888
2024-02-08 2024-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.040 504.919 -0,60 142,18 -432.218 71.787.919
2024-02-02 2024-01-31 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.707 502.188 -0,54 140,69 -380.845 70.652.227
2024-01-10 2024-01-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -62.023 499.754 -11,04 134,01 -8.311.895 66.973.583
2024-01-10 2024-01-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 62.023 561.777 12,41 19,59 1.215.031 11.005.211
2024-01-10 2024-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -105.835 499.754 -17,48 132,44 -14.016.523 66.186.170
2024-01-10 2024-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 105.835 605.589 21,18 19,59 2.073.308 11.863.489
2023-08-23 2023-08-21 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -9.328 499.754 -1,83 107,40 -1.001.816 53.672.980
2023-06-22 2023-06-20 4 XNCR Xencor Inc
Common Stock
A - Award 5.007 5.007
2023-02-08 2023-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.274 491.365 -0,46 104,30 -237.185 51.250.745
2023-02-08 2023-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -20.482 489.322 -4,02 102,43 -2.098.049 50.123.112
2023-02-08 2023-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.248 470.930 -0,68 102,30 -332.266 48.175.433
2023-02-08 2023-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.040 468.008 -0,65 105,68 -321.259 49.457.775
2023-02-02 2023-01-31 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.707 465.278 -0,58 110,08 -297.997 51.219.617
2022-02-09 2022-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.274 462.844 -0,49 79,49 -180.768 36.792.951
2022-02-09 2022-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.040 460.801 -0,66 80,80 -245.630 37.232.444
2022-02-09 2022-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.248 458.071 -0,70 80,82 -262.518 37.023.360
2022-02-09 2022-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.422 455.150 -0,53 80,83 -195.759 36.787.590
2022-02-02 2022-01-31 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 20.565 20.565
2022-02-02 2022-01-31 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 140.049 140.049
2021-06-25 2021-06-24 4 XNCR Xencor Inc
Stock Option (Right to Buy)
A - Award 9.728 9.728
2021-03-29 2021-02-08 4/A NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 113.863 113.863
2021-02-09 2021-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 17.269 17.269
2021-02-09 2021-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 103.609 103.609
2021-02-09 2021-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.248 452.972 -0,71 116,71 -379.089 52.868.491
2021-02-09 2021-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -4.343 450.051 -0,96 116,74 -506.999 52.538.684
2021-02-09 2021-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.875 446.144 -0,64 116,79 -335.775 52.105.738
2021-02-09 2021-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.422 443.249 -0,54 114,16 -276.504 50.602.946
2021-01-12 2021-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -164.801 0 -100,00 8,65 -1.425.529
2021-01-12 2021-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -143.449 0 -100,00 8,66 -1.242.268
2021-01-12 2021-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -164.801 441.071 -27,20 110,22 -18.164.778 48.615.948
2021-01-12 2021-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 164.801 605.872 37,36 8,65 1.425.529 5.240.793
2021-01-12 2021-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -143.449 441.071 -24,54 110,21 -15.809.098 48.609.156
2021-01-12 2021-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 143.449 584.520 32,52 8,66 1.242.268 5.061.943
2020-11-16 2020-11-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.390 441.071 -0,76 90,78 -307.748 40.040.866
2020-08-07 2020-08-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale -3.390 438.021 -0,77 118,91 -403.101 52.084.595
2020-04-28 2020-04-24 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.906 434.971 -0,66 99,45 -289.016 43.259.954
2020-02-11 2020-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.248 432.357 -0,75 103,35 -335.696 44.686.128
2020-02-07 2020-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 23.081 23.081
2020-02-07 2020-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 145.698 145.698
2020-02-07 2020-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -4.343 429.436 -1,00 101,56 -441.068 43.612.790
2020-02-07 2020-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.422 425.529 -0,57 103,09 -249.693 43.869.359
2020-02-07 2020-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.027 423.351 -0,71 103,08 -312.033 43.640.376
2019-08-13 2019-08-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -3.031 0 -100,00 32,99 -99.993
2019-08-13 2019-08-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 3.031 420.628 0,73 32,99 99.993 13.876.518
2019-08-08 2019-08-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -26.330 143.449 -15,51 8,66 -228.018 1.242.268
2019-08-08 2019-08-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -26.330 417.597 -5,93 95,64 -2.518.154 39.938.225
2019-08-08 2019-08-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 26.330 443.927 6,31 8,66 228.018 3.844.408
2019-08-08 2019-08-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -2.759 169.779 -1,60 8,66 -23.893 1.470.286
2019-08-08 2019-08-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.759 417.597 -0,66 95,12 -262.440 39.722.495
2019-08-08 2019-08-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 2.759 420.356 0,66 8,66 23.893 3.640.283
2019-08-08 2019-08-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -50.911 172.538 -22,78 8,66 -440.889 1.494.179
2019-08-08 2019-08-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -50.911 417.597 -10,87 95,15 -4.844.380 39.735.983
2019-08-08 2019-08-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 50.911 468.508 12,19 8,66 440.889 4.057.279
2019-06-27 2019-06-26 4 XNCR Xencor Inc
Stock Option (Right to Buy)
A - Award 12.731 12.731
2019-02-08 2019-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 24.677 24.677
2019-02-08 2019-02-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 133.345 133.345
2019-02-08 2019-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -4.096 417.597 -0,97 84,22 -344.986 35.172.107
2019-02-06 2019-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -1.992 413.943 -0,48 88,28 -175.853 36.542.805
2019-02-06 2019-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.497 410.185 -0,61 88,12 -220.042 36.146.528
2019-02-06 2019-02-04 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.125 408.082 -0,76 88,10 -275.321 35.953.126
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -864 3.031 -22,18 32,99 -28.503 99.993
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -7.142 0 -100,00 19,59 -139.912
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -10.199 0 -100,00 8,65 -88.221
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -16.551 0 -100,00 8,66 -143.332
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -23.168 0 -100,00 5,76 -133.448
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 864 404.957 0,21 32,99 28.503 13.359.531
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 7.142 404.093 1,80 19,59 139.912 7.916.182
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 10.199 396.951 2,64 8,65 88.221 3.433.626
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 16.551 386.752 4,47 8,66 143.332 3.349.272
2018-06-29 2018-06-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 23.168 370.201 6,68 5,76 133.448 2.132.358
2018-06-27 2018-06-26 4 XNCR Xencor Inc
Stock Option (Right to Buy)
A - Award 7.500 7.500
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -126.832 0 -100,00 5,76 -730.552
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -126.832 347.033 -26,77 80,75 -10.241.735 28.023.054
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 126.832 473.865 36,55 5,76 730.552 2.729.462
2018-02-07 2018-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -100.000 126.832 -44,09 5,76 -576.000 730.552
2018-02-07 2018-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes -4.091 347.033 -1,17 82,48 -337.426 28.623.282
2018-02-07 2018-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -100.000 342.874 -22,58 80,07 -8.006.620 27.452.618
2018-02-07 2018-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 100.000 442.874 29,17 5,76 576.000 2.550.954
2018-02-07 2018-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 18.400 18.400
2018-02-07 2018-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 18.400 18.400
2018-02-07 2018-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 104.200 104.200
2018-02-07 2018-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale -2.858 342.874 -0,83 83,46 -238.543 28.617.978
2018-02-07 2018-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale -3.125 339.482 -0,91 83,08 -259.621 28.203.723
2018-01-18 2018-01-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale -3.750 336.357 -1,10 78,89 -295.820 26.533.623
2017-06-26 2017-06-22 4 XNCR Xencor Inc
Stock Option (Right to Buy)
A - Award 7.500 7.500
2017-05-03 2017-05-02 4 NBIX NEUROCRINE BIOSCIENCES INC
Employee Stock Option (right to buy)
M - Exercise -21.739 0 -100,00 2,59 -56.304
2017-05-03 2017-05-02 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -21.739 332.607 -6,13 53,23 -1.157.167 17.704.671
2017-05-03 2017-05-02 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 21.739 354.346 6,54 2,59 56.304 917.756
2017-04-17 2017-04-17 4 XNCR Xencor Inc
Stock Option (Right to Buy)
A - Award 15.000 15.000
2017-04-17 3 XNCR Xencor Inc
No securities are beneficially owned.
0
2017-04-13 2017-04-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -306 332.607 -0,09 51,23 -15.676 17.039.457
2017-04-13 2017-04-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -19.290 332.913 -5,48 50,41 -972.409 16.782.144
2017-02-08 2017-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Employee Stock Option (Right to Buy)
M - Exercise -64.161 21.739 -74,69 2,59 -166.177 56.304
2017-02-08 2017-02-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 64.161 314.703 25,61 2,59 166.177 815.081
2017-02-08 2017-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Option
A - Award 33.400 33.400
2017-02-08 2017-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 207.400 207.400
2017-02-08 2017-02-06 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.010 250.542 -1,19 43,18 -129.972 10.818.404
2017-02-06 2017-02-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.125 247.802 -1,25 42,55 -132.969 10.543.975
2017-01-18 2017-01-17 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.750 244.677 -1,51 40,65 -152.438 9.946.120
2017-01-12 2017-01-10 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.750 240.927 -1,53 43,28 -162.300 10.427.321
2016-12-23 2016-12-23 4 NBIX NEUROCRINE BIOSCIENCES INC
Employee Stock Option (right to buy)
M - Exercise -9.100 85.900 -9,58 2,59 -23.569 222.481
2016-12-23 2016-12-23 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 9.100 237.177 3,99 2,59 23.569 614.288
2016-02-09 2016-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 35.750 35.750
2016-02-09 2016-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 109.100 109.100
2016-02-09 2016-02-05 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 23.000 23.000
2016-02-04 2016-02-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale -3.125 228.077 -1,35 38,04 -118.875 8.676.049
2016-01-21 2016-01-19 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale -3.750 224.952 -1,64 46,70 -175.125 10.505.258
2016-01-13 2016-01-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale -3.750 221.202 -1,67 44,17 -165.638 9.770.492
2015-10-19 2015-10-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -33.500 217.452 -13,35 47,77 -1.600.295 10.387.682
2015-03-24 2015-03-24 4 NBIX NEUROCRINE BIOSCIENCES INC
Nonqualified Stock Option
M - Exercise -40.000 95.000 -29,63 2,59 -103.600 246.050
2015-03-24 2015-03-24 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -40.000 188.452 -17,51 41,53 -1.661.200 7.826.412
2015-03-24 2015-03-24 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 40.000 228.452 21,23 2,59 103.600 591.691
2015-02-05 2015-02-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 150.000 150.000 32,99 4.948.500 4.948.500
2015-02-05 2015-02-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 25.000 25.000
2015-01-21 2015-01-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.750 188.452 -1,95 30,79 -115.462 5.802.437
2015-01-13 2015-01-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.750 184.702 -1,99 28,43 -106.612 5.251.078
2015-01-09 2015-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Nonqualified Stock Option
M - Exercise -25.000 135.000 -15,62 2,59 -64.750 349.650
2015-01-09 2015-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -25.000 180.952 -12,14 27,39 -684.750 4.956.275
2015-01-09 2015-01-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 25.000 205.952 13,82 2,59 64.750 533.416
2014-12-19 2014-12-19 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -15.000 0 -100,00 5,12 -76.800
2014-12-19 2014-12-19 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -15.000 180.952 -7,65 24,01 -360.150 4.344.658
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Nonqualified Stock Option
M - Exercise -14.474 15.000 -49,11 5,12 -74.107 76.800
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
M - Exercise -15.526 29.474 -34,50 5,12 -79.493 150.907
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Nonqualified Stock Option
M - Exercise -25.000 160.000 -13,51 2,59 -64.750 414.400
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15.000 195.952 8,29 5,12 76.800 1.003.274
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -30.000 180.952 -14,22 23,24 -697.200 4.205.324
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 30.000 210.952 16,58 5,12 153.600 1.080.074
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -25.000 180.952 -12,14 23,24 -581.000 4.205.324
2014-12-19 2014-12-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 25.000 205.952 13,82 2,59 64.750 533.416
2014-01-21 2014-01-16 4 NBIX NEUROCRINE BIOSCIENCES INC
RESTRICTED STOCK UNIT
A - Award 100.000 100.000
2014-01-21 2014-01-16 4 NBIX NEUROCRINE BIOSCIENCES INC
RESTRICTED STOCK UNIT
A - Award 30.000 30.000
2014-01-21 2014-01-16 4 NBIX NEUROCRINE BIOSCIENCES INC
STOCK OPTION
A - Award 175.000 175.000 19,59 3.428.250 3.428.250
2014-01-13 2014-01-10 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -3.750 180.952 -2,03 18,57 -69.638 3.360.279
2014-01-08 2014-01-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Incentive Stock Option
X - Other 6.854 0 -100,00 11,44 78.410
2014-01-08 2014-01-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Nonstatutory Stock Option
X - Other 101.146 6.854 -107,27 11,44 1.157.110 78.410
2014-01-08 2014-01-07 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -108.000 177.202 -37,87 16,76 -1.810.080 2.969.906
2013-01-14 2013-01-10 4 NBIX NEUROCRINE BIOSCIENCES INC
Restricted Stock Unit
A - Award 30.000 30.000
2013-01-14 2013-01-10 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 175.000 175.000 8,65 1.513.750 1.513.750
2012-01-17 2012-01-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 240.000 240.000 8,66 2.078.400 2.078.400
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)